rxstat › Drug prices › Vilanterol Umeclidinium Fluticasone Furoate

Vilanterol Umeclidinium Fluticasone Furoate (Trelegy Ellipta) price in Canada

No current shortage

Source: Health Canada shortage reports · Updated Jul 9, 2026

Vilanterol Umeclidinium Fluticasone Furoate 100 mcg/act / 62.5 mcg/act / 25 mcg/act powder costs about $137.67 per billed unit (often a pen or vial) on public drug plan price lists across 2 provinces, before the pharmacy's dispensing fee.

Vilanterol Umeclidinium Fluticasone Furoate has no current shortage reported in Canada. No active reports are on file.

Price by province

Strength and formABSKONNBNS
100 mcg/act / 62.5 mcg/act / 25 mcg/act Powder$4.59/unit$137.67/unit$137.67/unit$4.59/dose$4.59/unit
200 mcg/act / 62.5 mcg/act / 25 mcg/act Powder$5.03/unitnot covered––––
Plan coverageCoveredSpecial approvalCoveredSpecial approvalSpecial approval

Lowest price per unit among each province's covered products, with the brand price where it is notably higher. A dash means the province does not list it. Provinces bill some products (injectables especially) per mL and others per pen or vial, so compare prices with the same unit.

Detailed price and coverage in your province:

What you'll pay at the pharmacy

These are the prices public drug plans list for the drug itself. At the counter, pharmacies add a dispensing fee and in some provinces a markup, so paying cash costs more, and for cheap generics the fee is often more than the drug. If you have a public or private plan, your share depends on its deductible and co-pay.

Listed products by province

Alberta: 2 products
  • Trelegy Ellipta 100 mcg/act / 62.5 mcg/act / 25 mcg/act Powder · GSK
    DIN 02474522 · $4.59/unit · Covered
  • Trelegy Ellipta 200 mcg/act / 62.5 mcg/act / 25 mcg/act Powder · GSK
    DIN 02515776 · $5.03/unit · Not covered
Saskatchewan: 1 product
  • Trelegy Ellipta 100 mcg/act / 62.5 mcg/act / 25 mcg/act Powder · GSK
    DIN 02474522 · $137.67/unit · Special approval
Ontario: 1 product
  • Trelegy Ellipta 100 mcg/act / 62.5 mcg/act / 25 mcg/act Powder · GlaxoSmithKline Inc., GlaxoSmithKline Consumer Health Care
    DIN 02474522 · $137.67/unit · Covered
New Brunswick: 1 product
  • Trelegy Ellipta 100 mcg/act / 62.5 mcg/act / 25 mcg/act Powder · GSK
    DIN 02474522 · $4.59/dose · Special approval
Nova Scotia: 1 product
  • Trelegy Ellipta 100 mcg/act / 62.5 mcg/act / 25 mcg/act Powder · GSK
    DIN 02474522 · $4.59/unit · Special approval

Price sources: Ontario Drug Benefit Formulary (Oct 30, 2026) · Alberta Drug Benefit List and Alberta Blue Cross price list (Nov 1, 2026) · Saskatchewan Drug Plan Formulary (Nov 1, 2026) · New Brunswick Drug Plans Formulary (Nov 1, 2026) · Nova Scotia Pharmacare Formulary (Nov 1, 2026). Other provinces and territories will be added as their public price lists are brought in.

Shortage status

Products affected
0 / 1
Reports on file
1

Shortage history

2023 2024 2025 2026

Shortage history (red bands = periods in shortage).

Reports by product

Resolved
TRELEGY ELLIPTA
25MCG 62.5MCG 100MCG · POWDER · GLAXOSMITHKLINE INC
DIN 02474522 · ended Jan 3, 2023 · Demand increase for the drug.

What's happening

There are no active shortage reports for Vilanterol Umeclidinium Fluticasone Furoate.

Recent changes

Common questions

How much does Vilanterol Umeclidinium Fluticasone Furoate cost in Canada?

Vilanterol Umeclidinium Fluticasone Furoate 100 mcg/act / 62.5 mcg/act / 25 mcg/act powder costs about $137.67 per billed unit (often a pen or vial) on public drug plan price lists across 2 provinces, before the pharmacy's dispensing fee.

Is Vilanterol Umeclidinium Fluticasone Furoate covered by provincial drug plans?

On the public plans' own lists: Alberta: covered; Saskatchewan: special approval; Ontario: covered; New Brunswick: special approval; Nova Scotia: special approval. "Special approval" means the plan covers it only for some patients, on a request from the prescriber. "Price list" means the province publishes its price but not its coverage.

When will Vilanterol Umeclidinium Fluticasone Furoate be back in stock in Canada?

Vilanterol Umeclidinium Fluticasone Furoate has no active shortage; supply is normal per Health Canada reports.

Why is Vilanterol Umeclidinium Fluticasone Furoate in shortage?

It isn't currently. Past reports and their reasons are listed above.

What can my pharmacist do about it?

Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.

Email alerts

Get an email when this drug's status changes. Double opt-in, one-click unsubscribe.

Related drugs

Guides: what to do when your medication is in shortage · how to read shortage reports

Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.